Combination therapy with interferon alpha and ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients
Telfer, P.T.; Whitby, K.; Grant, P.; Garson, J.A.; Hoffbrand, A.V.; Wonke, B.
Blood 88(10 Suppl 1 Part 1-2): 527A
1996
ISSN/ISBN: 0006-4971 Accession: 030605023
PDF emailed within 1 workday: $29.90
Related References
Telfer, P.T.; Whitby, K.; Garson, J.A.; Hoffbrand, A.V.; Wonke, B. 1995: Alpha interferon alone and in combination with ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients Blood 86(10 Suppl 1): 484ATelfer, P.T.; Garson, J.A.; Whitby, K.; Grant, P.R.; Yardumian, A.; Hoffbrand, A.V.; Wonke, B. 1997: Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients British Journal of Haematology 98(4): 850-855
Hung, C-Hung.; Lee, C-Mo.; Lu, S-Nan.; Wang, J-Houng.; Tung, H-Da.; Chen, C-Hung.; Changchien, C-Sin. 2005: Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection Journal of Gastroenterology and Hepatology 20(5): 727-732
Cheng, P.-N.; Jen, C.-M.; Young, K.-C.; Chen, C.-Y.; Lu, S.-N.; Wang, C.-S.; Chang, T.-T. 2003: High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C Hepato-Gastroenterology 50(50): 449-452
Delić, D.; Mitrović, N.; Popović, N.ša.; Urošević, A.; Pešiċ, I.; Simonoviċ, J. 2012: Antiviral/immunomodulatory combination therapy: pegylated interferon alpha 2a and ribavirin in patients with chronic hepatitis C virus infection Srpski Arhiv Za Celokupno Lekarstvo 140(9-10): 612-618
Donohue, S.M.; Wonke, B.; Dusheiko, G.; Hoffbrand, A.V. 1991: Alpha interferon therapy of hepatitis c in multiply transfused thalassaemia patients Journal of Interferon Research 11(Suppl 1): S124
Zheng, Y.-h.; He, Y.; Yang, X.; Gong, G.-z.; Zhou, H.-y.; Zhang, C.-y.; Zhou, W.; Huang, L.; Ding, P.-p.; Li, H. 2005: Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus Zhonghua Gan Zang Bing Za Zhi 13(10): 741-744
Sulkowski, M.S.; Wasserman, R.; Brooks, L.; Ball, L.; Gish, R. 2004: Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection Journal of Viral Hepatitis 11(3): 243-250
Hassanein, T.I.; Barakat, F.M.; Behling, C.; Myers, W.Y.; Carlson, M.D.; Chatfield, E.R.; Selim, K.M. 2003: Effects of the combination of Peg-Interferon Alpha-2b and Ribavirin on the inflammation and fibrosis scores of patients with chronic hepatitis C infection who were virologic non-responders to Interferon Alpha-2b and Ribavirin American Journal of Gastroenterology 98(9 Suppl): S103-S104
Lagasse, J.P.; Causse, X.; Boulet, J.M.; Djarech, H.; Ripault, M.P.; Labarriere, D. 2001: Correction of immune thrombocytopenia associated with hepatitis C virus infection after combination therapy with interferon alpha and ribavirin Gastroenterologie Clinique et Biologique 25(4): 429-430
Ben-Ari, Z.; Mor, E.; Shaharabani, E.; Bar-Nathan, N.; Shapira, Z.; Tur-Kaspa, R. 2000: Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation Transplantation Proceedings 32(4): 714-716
Itokawa, N.; Atsukawa, M.; Tsubota, A.; Kondo, C.; Hashimoto, S.; Fukuda, T.; Matsushita, Y.; Kidokoro, H.; Kobayashi, T.; Narahara, Y.; Nakatsuka, K.; Kanazawa, H.; Iwakiri, K.; Sakamoto, C. 2013: Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype Journal of Gastroenterology and Hepatology 28(3): 443-449
Kwo, P.Y.; Pound, D.C.; Fields, S.; Glowinski, E.A.; Born, L.; Chalasani, N.; Cho, W.; Crabb, D.W.; Cummings, O.W.; Imperiale, T.; Lumeng, L.; Mcgill, J.; Ness, R. 1998: Combination therapy with ribavirin plus alpha interferon for the treatment of chronic hepatitis secondary to hepatitis C virus in patients who have failed treatment with alpha interferon Gastroenterology 114(4 Part 2): A1281
Tatsumi, T.; Takehara, T.; Miyagi, T.; Nakazuru, S.; Mita, E.; Kanto, T.; Hiramatsu, N.; Hayashi, N. 2011: Hepatitis C virus-specific CD8+ T cell frequencies are associated with the responses of pegylated interferon-α and ribavirin combination therapy in patients with chronic hepatitis C virus infection Hepatology Research: the Official Journal of the Japan Society of Hepatology 41(1): 30-38
Nakagawa, M.; Sakamoto, N.; Ueyama, M.; Mogushi, K.; Nagaie, S.; Itsui, Y.; Azuma, S.; Kakinuma, S.; Tanaka, H.; Enomoto, N.; Watanabe, M. 2010: Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection Journal of Gastroenterology 45(6): 656-665